Dennis McLoughlin - 06 Jun 2023 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Customer Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
06 Jun 2023
Net transactions value
-$79,560
Form type
4
Filing time
07 Jun 2023, 21:24:37 UTC
Previous filing
08 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $39,537 -1,014 -2.5% $38.99 39,172 06 Jun 2023 Direct F1, F2
transaction PCRX Common Stock Sale $40,023 -1,057 -2.7% $37.86 38,115 07 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
F2 Includes an aggregate of 416 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022.